Manifold Partners’s Avanos Medical AVNS Stock Holding History

Manifold Partners’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-82	Closed	-$3K	–	87
2015 Q2	$3K	Hold	82	–	–	﹤0.01%	67
2015 Q1	$4K	Sell	82 -23	-22%	-$1.06K	﹤0.01%	61
2014 Q4	$5K	Buy	+105	New	+$4.13K	0.01%	50

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Manifold Partners's AVNS Position: Q3 2015 in Review

Manifold Partners sold out of Avanos Medical (AVNS) in Q3 2015, closing a stake of 82 shares — an estimated $3K sold.

Manifold Partners first reported a position in AVNS in Q4 2014 and held it in 3 quarters. The position peaked at $5K in Q4 2014. 353 funds tracked by Wall St. Rank hold AVNS as of Q3 2015.

Manifold Partners reported no remaining Avanos Medical position as of Q3 2015 after selling out during the quarter.
Manifold Partners sold 82 Avanos Medical shares in Q3 2015, an estimated $3K.
Manifold Partners first reported a position in Avanos Medical in Q4 2014 and held it in 3 quarters.
Manifold Partners's Avanos Medical position peaked at $5K in Q4 2014.
353 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2015.

Based on Manifold Partners's 13F filing for Q3 2015, filed 4 Nov 2015.